VTMX vs IOVA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
VTMX · Vesta Real Estate$34.39 ▼ 0.35%
IOVA · Iovance Biotherapeutics$6.90 ▼ 5.61%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- VTMX +15.5%
- IOVA +176.0%
Head to head
| Metric | VTMX | IOVA |
|---|---|---|
| Price | $34.39 | $6.90 |
| Change today | ▼ 0.35% | ▼ 5.61% |
| Market cap | $3.19B | $3.19B |
| Return, 3 months | -3.1% | -14.4% |
| Return, year to date | +14.2% | +152.7% |
| Return, 1 year | +13.9% | +208.0% |
| P/E (TTM) | 6.2 | – |
| P/B | 1.0 | 3.9 |
| P/E percentile vs own 5y | 15th | 2nd |
| Dividend yield | 2.41% | – |
| Revenue growth (YoY, latest qtr) | +9.9% | +80.1% |
| Net profit growth (YoY) | +342.4% | +75.6% |
| Gross margin | 89.4% | 53.2% |
| Operating margin | 77.7% | -60.8% |
| Net margin | 156.7% | -58.2% |
| Return on equity | 16.7% | -29.1% |
| Analyst target vs. price | – | +137.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 36 | 29 |
| 30-day volatility | 26.3% | 144.6% |
| Max drawdown, 1 year | -14.3% | -53.6% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IOVA is the largest of the group by market value.
- IOVA has returned the most over the past year.
- IOVA is growing revenue fastest.
- VTMX keeps the most profit per dollar of sales.
- VTMX has been the calmest stock over the last 30 days.